Skip to main content
Erschienen in: Supportive Care in Cancer 3/2009

01.03.2009 | Short Communication

Clostridium difficile-associated disease in children with solid tumors

verfasst von: Elio Castagnola, Teresa Battaglia, Roberto Bandettini, Ilaria Caviglia, Ivana Baldelli, Marilina Nantron, Cristina Moroni, Alberto Garaventa

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Goals of work

The goal of this study was to describe the incidence of Clostridium difficile-associated disease (CDAD) in children with solid tumours.

Patients and methods

After documentation of a case of C. difficile-associated pseudomembranous colitis in a patient with neuroblastoma, the presence of C. difficile toxins A and B was prospectively tested in all children undergoing antineoplastic chemotherapy for solid tumours or lymphomas at the “G. Gaslini” Children Hospital in Genoa who presented abdominal pain.

Main results

From January 2005 to December 2006, nine (6%) out of 141 patients treated for solid tumours had C. difficile toxin A detected in their stools in the presence of abdominal symptoms including vomit, abdominal pain and diarrhoea. The majority of patients had a normal neutrophil count at onset of gastrointestinal disease No patient developed pseudomembranous colitis, and none died. All patients received antibiotics and/or antineoplastic drugs previously associated with CDAD.

Conclusions

CDAD may be a complication of children with solid tumours. Since this disease may be life threatening and cause epidemic clusters, this possibility must be kept in mind for the differential diagnosis of abdominal diseases in children with cancer, especially in absence of neutropenia.
Literatur
1.
Zurück zum Zitat Anand A, Glatt AE (1993) Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 17:109–113PubMed Anand A, Glatt AE (1993) Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 17:109–113PubMed
2.
Zurück zum Zitat Anonimous (1994) Clostridium difficile. In: Philpott-Howard J, Casewell M (eds) Hospital infection control. Policies & practical procedures. Saunders, London, pp 62–64 Anonimous (1994) Clostridium difficile. In: Philpott-Howard J, Casewell M (eds) Hospital infection control. Policies & practical procedures. Saunders, London, pp 62–64
3.
Zurück zum Zitat Bilgrami S, Feingold JM, Dorsky D, Edwards RL, Bona RD, Khan AM et al (1999) Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 23:1039–1042 doi:10.1038/sj.bmt.1701773 PubMedCrossRef Bilgrami S, Feingold JM, Dorsky D, Edwards RL, Bona RD, Khan AM et al (1999) Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 23:1039–1042 doi:10.​1038/​sj.​bmt.​1701773 PubMedCrossRef
4.
Zurück zum Zitat Brito GA, Sullivan GW, Ciesla WP Jr, Carper HT, Mandell GL, Guerrant RL (2002) Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function. J Infect Dis 185:1297–1306 doi:10.1086/340236 PubMedCrossRef Brito GA, Sullivan GW, Ciesla WP Jr, Carper HT, Mandell GL, Guerrant RL (2002) Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function. J Infect Dis 185:1297–1306 doi:10.​1086/​340236 PubMedCrossRef
5.
Zurück zum Zitat Collignon A, Chaumard C, Vallet-Collomb I, Delepine N (1988) Clostridium difficile in children and adolescents undergoing anticancer and antimicrobial chemotherapy. The possibility of nosocomial acquisition. Pathol Biol (Paris) 36:754–758 Collignon A, Chaumard C, Vallet-Collomb I, Delepine N (1988) Clostridium difficile in children and adolescents undergoing anticancer and antimicrobial chemotherapy. The possibility of nosocomial acquisition. Pathol Biol (Paris) 36:754–758
6.
Zurück zum Zitat Correa AG (2004) Clostridial Intoxication and infection. In: Feigin RD, Cherry JD, Demmler GJ, Kaplan SL (eds) Textbook of pediatric infectious diseases. Saunders, Philadelphia, pp 1751–1758 Correa AG (2004) Clostridial Intoxication and infection. In: Feigin RD, Cherry JD, Demmler GJ, Kaplan SL (eds) Textbook of pediatric infectious diseases. Saunders, Philadelphia, pp 1751–1758
8.
Zurück zum Zitat Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ (2007) Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45:1543–1549 doi:10.1086/523582 PubMedCrossRef Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ (2007) Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45:1543–1549 doi:10.​1086/​523582 PubMedCrossRef
10.
Zurück zum Zitat Laret V, Sion C, Bataille C, Hustinx R, Reginster M (2006) Clinical case of the month: clostridium difficile colitis. Rev Med Liege 61:750–752PubMed Laret V, Sion C, Bataille C, Hustinx R, Reginster M (2006) Clinical case of the month: clostridium difficile colitis. Rev Med Liege 61:750–752PubMed
14.
Zurück zum Zitat Pothoulakis C, Sullivan R, Melnick DA, Triadafilopoulos G, Gadenne AS, Meshulam T et al (1988) Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. J Clin Invest 81:1741–1745 doi:10.1172/JCI113514 PubMedCrossRef Pothoulakis C, Sullivan R, Melnick DA, Triadafilopoulos G, Gadenne AS, Meshulam T et al (1988) Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. J Clin Invest 81:1741–1745 doi:10.​1172/​JCI113514 PubMedCrossRef
15.
Zurück zum Zitat Schuller I, Saha V, Lin L, Kingston J, Eden T, Tabaqchali S (1995) Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit. Arch Dis Child 72:219–222PubMedCrossRef Schuller I, Saha V, Lin L, Kingston J, Eden T, Tabaqchali S (1995) Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit. Arch Dis Child 72:219–222PubMedCrossRef
16.
Zurück zum Zitat Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D et al (2008) Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 8:70 doi:10.1186/1471-2334-8-70 PubMedCrossRef Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D et al (2008) Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 8:70 doi:10.​1186/​1471-2334-8-70 PubMedCrossRef
17.
Zurück zum Zitat Thielman NM, Wilson KH (2005) Antibiotic-associated colitis. In: Mandell GL, Bennett JE, Doolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 1249–1263 Thielman NM, Wilson KH (2005) Antibiotic-associated colitis. In: Mandell GL, Bennett JE, Doolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 1249–1263
18.
Zurück zum Zitat Viscoli C, Castagnola E (2005) Prophylaxis and empirical therapy for infection in cancer patients. In: Mandell GL, Bennett JE, Doolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 3442–3462 Viscoli C, Castagnola E (2005) Prophylaxis and empirical therapy for infection in cancer patients. In: Mandell GL, Bennett JE, Doolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 3442–3462
20.
Zurück zum Zitat Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freeman J (2003) Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect 54:109–114 doi:10.1016/S0195-6701(02)00400-0 PubMedCrossRef Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freeman J (2003) Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect 54:109–114 doi:10.​1016/​S0195-6701(02)00400-0 PubMedCrossRef
Metadaten
Titel
Clostridium difficile-associated disease in children with solid tumors
verfasst von
Elio Castagnola
Teresa Battaglia
Roberto Bandettini
Ilaria Caviglia
Ivana Baldelli
Marilina Nantron
Cristina Moroni
Alberto Garaventa
Publikationsdatum
01.03.2009
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 3/2009
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0507-0

Weitere Artikel der Ausgabe 3/2009

Supportive Care in Cancer 3/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.